These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37022211)

  • 1. In vivo evolution to echinocandin resistance and increasing clonal heterogeneity in
    Codda G; Willison E; Magnasco L; Morici P; Giacobbe DR; Mencacci A; Marini D; Mikulska M; Bassetti M; Marchese A; Di Pilato V
    Euro Surveill; 2023 Apr; 28(14):. PubMed ID: 37022211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Non-Hot Spot Modification in Fks1 of Candida auris Confers Echinocandin Resistance.
    Kordalewska M; Cancino-Prado G; Nobrega de Almeida Júnior J; Brasil Brandão I; Tigulini de Souza Peral R; Colombo AL; Perlin DS
    Antimicrob Agents Chemother; 2023 Jun; 67(6):e0042323. PubMed ID: 37222585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris.
    Kordalewska M; Lee A; Park S; Berrio I; Chowdhary A; Zhao Y; Perlin DS
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632013
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular characterization of Candida auris outbreak isolates in Qatar from patients with COVID-19 reveals the emergence of isolates resistant to three classes of antifungal drugs.
    Ben Abid F; Salah H; Sundararaju S; Dalil L; Abdelwahab AH; Salameh S; Ibrahim EB; Almaslmani MA; Tang P; Perez-Lopez A; Tsui CKM
    Clin Microbiol Infect; 2023 Aug; 29(8):1083.e1-1083.e7. PubMed ID: 37116861
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Maphanga TG; Mpembe RS; Naicker SD; Govender NP;
    Microbiol Spectr; 2022 Feb; 10(1):e0171721. PubMed ID: 35196811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacies of the three echinocandins for Candida auris candidemia: real world evidence from a tertiary centre in India.
    Prayag PS; Patwardhan SA; Joshi RS; Dhupad S; Rane T; Prayag AP
    Med Mycol; 2024 Jul; 62(7):. PubMed ID: 38918058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptomics and Phenotyping Define Genetic Signatures Associated with Echinocandin Resistance in Candida auris.
    Jenull S; Shivarathri R; Tsymala I; Penninger P; Trinh PC; Nogueira F; Chauhan M; Singh A; Petryshyn A; Stoiber A; Chowdhary A; Chauhan N; Kuchler K
    mBio; 2022 Aug; 13(4):e0079922. PubMed ID: 35968956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Echinocandin Resistance in Candida auris Occurs in the Murine Gastrointestinal Tract Due to
    Hirayama T; Miyazaki T; Sumiyoshi M; Ito Y; Ashizawa N; Takeda K; Iwanaga N; Takazono T; Yamamoto K; Izumikawa K; Yanagihara K; Makimura K; Tsukamoto K; Kohno S; Mukae H
    Antimicrob Agents Chemother; 2023 Apr; 67(4):e0124322. PubMed ID: 36920237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole genome sequencing analysis demonstrates therapy-induced echinocandin resistance in Candida auris isolates.
    Spruijtenburg B; Ahmad S; Asadzadeh M; Alfouzan W; Al-Obaid I; Mokaddas E; Meijer EFJ; Meis JF; de Groot T
    Mycoses; 2023 Dec; 66(12):1079-1086. PubMed ID: 37712885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of
    Sharma D; Paul RA; Rudramurthy SM; Kashyap N; Bhattacharya S; Soman R; Shankarnarayan SA; Chavan D; Singh S; Das P; Kaur H; Ghosh AK; Prasad R; Sanyal K; Chakrabarti A
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0165221. PubMed ID: 34780273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rezafungin
    Helleberg M; Jørgensen KM; Hare RK; Datcu R; Chowdhary A; Arendrup MC
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deciphering Candida auris Paradoxical Growth Effect (Eagle Effect) in Response to Echinocandins.
    Kordalewska M; Perlin DS
    Methods Mol Biol; 2022; 2517():73-85. PubMed ID: 35674946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemia.
    Calvo B; Melo AS; Perozo-Mena A; Hernandez M; Francisco EC; Hagen F; Meis JF; Colombo AL
    J Infect; 2016 Oct; 73(4):369-74. PubMed ID: 27452195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterisation of Candida auris isolates from immunocompromised patients in a tertiary-care hospital in Kuwait reveals a novel mutation in FKS1 conferring reduced susceptibility to echinocandins.
    Asadzadeh M; Mokaddas E; Ahmad S; Abdullah AA; de Groot T; Meis JF; Shetty SA
    Mycoses; 2022 Mar; 65(3):331-343. PubMed ID: 34953089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An outbreak due to Candida auris with prolonged colonisation and candidaemia in a tertiary care European hospital.
    Ruiz-Gaitán A; Moret AM; Tasias-Pitarch M; Aleixandre-López AI; Martínez-Morel H; Calabuig E; Salavert-Lletí M; Ramírez P; López-Hontangas JL; Hagen F; Meis JF; Mollar-Maseres J; Pemán J
    Mycoses; 2018 Jul; 61(7):498-505. PubMed ID: 29655180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Echinocandin antifungal drugs in fungal infections: a comparison.
    Chen SC; Slavin MA; Sorrell TC
    Drugs; 2011 Jan; 71(1):11-41. PubMed ID: 21175238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance.
    Chowdhary A; Prakash A; Sharma C; Kordalewska M; Kumar A; Sarma S; Tarai B; Singh A; Upadhyaya G; Upadhyay S; Yadav P; Singh PK; Khillan V; Sachdeva N; Perlin DS; Meis JF
    J Antimicrob Chemother; 2018 Apr; 73(4):891-899. PubMed ID: 29325167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global analysis of the evolution and mechanism of echinocandin resistance in Candida glabrata.
    Singh-Babak SD; Babak T; Diezmann S; Hill JA; Xie JL; Chen YL; Poutanen SM; Rennie RP; Heitman J; Cowen LE
    PLoS Pathog; 2012; 8(5):e1002718. PubMed ID: 22615574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of CD101, a long-acting echinocandin, against clinical isolates of Candida auris.
    Berkow EL; Lockhart SR
    Diagn Microbiol Infect Dis; 2018 Mar; 90(3):196-197. PubMed ID: 29307565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.